Introduction of foreign DNA into mycobacteria using a shuttle phasmid
The DOI matches its Crossref record.
Abstract
Mycobacteria are major pathogens of man and animals. There are approximately 10 million cases of tuberculosis world wide with an annual mortality of three million people. Leprosy, caused by Mycobacterium leprae, afflicts over ten million people, primarily in developing countries. M. tuberculosis and mycobacteria of the M. avium-intracellulare-scrofulaceum (MAIS) group are major opportunistic pathogens of patients with acquired immune deficiency syndrome (AIDS). M. paratuberculosis is the cause of Jöhne's disease in cattle. Yet, BCG (Bacille Calmette-Guerin), an avirulent strain of M. bovis, is the most widely used human vaccine in the world, having been administered to about 2.5 X 10(9) people since 1948 (ref. 4). BCG was highly protective against tuberculosis in England, but has been found not to be effective in preventing pulmonary tuberculosis in adults in Southern India. We have initiated studies to develop the methodology for efficient gene transfer in mycobacteria. We have constructed recombinant shuttle phasmids which are chimaeras containing mycobacteriophage DNA into which an E. coli cosmid is inserted. They can replicate in E. coli as plasmids and in mycobacteria as phages, and transfer DNA across both genera. These shuttle vectors permit for the first time the introduction of foreign DNA by infection into M. smegmatis and BCG. By introducing and ultimately expressing genes for protective antigens for a variety of pathogens, it may be possible to develop cultivatabl…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The shuttle phasmid replicates in E. coli as a plasmid and in mycobacteria as a phage (9, 11).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [9]
In the citing paper
“Foreign DNA was first introduced into mycobacteria in 1987 with a shuttle phasmid (9).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [9]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Research works printed but not linked: 1
- 1. Joint International Union Against Tuberculosis and World Health Organization Study Group Tubercle 63, 157–169 (1982). 2. Bloom, B. R. & Godal, T. Rev. infect. Dis. 5, 765–780 (1983). 3. Centers for Disease Control Morbid. Mortal, wkly. Rep. 34, 774 (1986). 4. United Nations Children's Emergency Fund (UNICEF) The State of the World's Children 131 (Oxford University Press, 1985). 5. Hart, P. D. & Sutherland, I. Br. Med. J. 2, 293–295 (1977). 6. Tuberculosis Prevention Trial, Madras Ind. J. med. Res. 72 (suppl.), 1–74 (1980). 7. Okanishi, M., Suzuki, K. & Umezawa, H. /. gen. Microbiol. 80, 389–400 (1974). 8. Hopwood, D. A. & Wright, H. M. Molec. Gen. Genet. 162, 307–317 (1978). 9. Bibb, M. J., Ward, J. M. & Hopwood, D. A. Nature 274, 398–400 (1978). 10. Crawford, J. T. & Bates, J. H. Infect. Immunity 24, 979–981 (1979). 11. Mizuguchi, Y., Fukunaga, M. & Taniguchi, H. /. Bact. 146, 656–659 (1981). 12. Meissner, P. S. & Falkinham, J. O. Ill J. Bact. 157, 669–672 (1984). 13. Labidi, A., David, H. L. & Roulland–Dussoix, D. Annls Microbiologie 136B, 209–215 (1985). 14. Brenner, S., Cesareni, G. & Karn, J. Gene 17, 27–44 (1982). 15. Suarez, J. E. & Chater, K. F. Nature 286, 527–529 (1980). 16. Timme, T. L. & Brennan, P. J. /. gen. Microbiol. 130, 2059–2066 (1984). 17. Collins, J. & Hohn, B. Proc. natn. Acad. Sci. U.S.A. 75, 4242–4246 (1978). 18. Hohn, B. & Collins, J. Gene 11, 291–298 (1980). 19. Lotte, A. et al. Adv. Tuberc. Res. 32, 107–193 (1984). 20. Hopwood, D. A. et al. In Genetic Manipulation of Streptomyces–A Laboratory Manual (John Innes Foundation, Norwich, 1985). 21. Froman, S., Will, D. W. & Bogen, E. Am. J. Public Health 44, 1326–1334 (1954). 22. Redmond, W. B. & Cater, J. C. Am. Rev. resp. Dis. 82, 781–787 (1960). 23. Udou, T., Ogawa, M. & Mizuguchi, Y. /. Bact. 151, 1035–1039 (1982). 24. Birnboim, H. C. & Doly, J. Nucleic Acids Res. 7, 1513–1525 (1979). 25. Benton, W. D. & Davis, R. W. Science 196, 180–182 (1977). 26. Southern, E. / molec. Biol. 98, 503–517 (1975). 27. Jones, W. D. Jr Tubercle, Lond. 60, 55–58 (1979). 28. Jones, W. D. Jr & Greenberg, J. /. din. Microbiol. 7, 467–469 (1978).
Cited by
Items 101–200 of 314
BCG vaccination in India and tuberculosis in children: Newer facets
Udani, P. M. (1994) · The Indian Journal of Pediatrics · doi:10.1007/bf02751703 · Cited by 51
Genetic advances for studying Mycobacterium tuberculosis pathogenicity
Pelicic, V., Reyrat, J., & Gicquel, B. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00807.x · Cited by 52
Antituberculous Immunity: New Solutions to an Old Problem
Collins, F. M. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.5.940 · Cited by 58
A half-century of research on tuberculosis: Successes and challenges
Bloom, B. R. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230859 · Cited by 49
“To overcome these hurdles, Jacobs et al. (1987) were able to create a genetic system in mycobacteria using phages capable of infecting Mycobacterium smegmatis, a rapidly growing, nonpathogenic mycobacterium, an unsung hero in TB research now widely used as a uniquely useful model organism for study…”
BackgroundSelf-citationMycobacteriophage ZoeJ: A broad host-range close relative of mycobacteriophage TM4
Dedrick, R. M., Guerrero-Bustamante, C. A., Garlena, R. A., Pinches, R. S., Cornely, K. A., & Hatfull, G. F. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.01.002 · Cited by 52
“A distinct ‘late’ pattern is observed with high levels of expression of the left arm genes (1-35) including the virion structural genes (1-25) and the lysis cassette (28-30) (Figs.”
BackgroundBarletta, R. G., Kim, D. D., Snapper, S. B., Bloom, B. R., & Jacobs, W. R. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-1-23 · Cited by 49
Self-citationMycobacteriophage Vector Systems
Jacobs, W. R., Snapper, S. B., Tuckman, M., & Bloom, B. R. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_2.s404 · Cited by 48
“combinant DNA vectors termed shuttle phasmids [11].”
MethodInfluentialSelf-citationLuo, Y., Henning, J., & O’Donnell, M. A. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/728930 · Cited by 48
Ruley, K. M., Ansede, J. H., Pritchett, C. L., Talaat, A. M., Reimschuessel, R., & Trucksis, M. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(04)00017-5 · Cited by 48
“, Albert Einstein College of Medicine, Bronx, NY, USA [9].”
Genome Sequence and Analysis of aPropionibacterium acnesBacteriophage
Farrar, M. D., Howson, K. M., Bojar, R. A., West, D., Towler, J. C., Parry, J., Pelton, K., & Holland, K. T. (2007) · Journal of Bacteriology · doi:10.1128/jb.00106-07 · Cited by 47
“The development of transformation systems and plasmid vectors for mycobacteria has allowed greater study of the genetics of these organisms (18, 27).”
BackgroundLugosi, L., Jacobs, W. R., & Bloom, B. R. (1989) · Tubercle · doi:10.1016/0041-3879(89)90046-9 · Cited by 47
Self-citationGenetic engineering of bacteriophages: Key concepts, strategies, and applications
Hussain, W., Yang, X., Ullah, M., Wang, H., Aziz, A., Xu, F., Asif, M., Ullah, M. W., & Wang, S. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108116 · Cited by 56
Molecular Biology, Virulence, and Pathogenicity of Mycobacteria
Shinnick, T. M., King, C. H., & Quinn, F. D. (1995) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199502000-00007 · Cited by 45
Bacterial Vaccine Vectors and Bacillus Calmette-Guerin
Cirillo, J. D., Stover, C. K., Bloom, B. R., Jacobs, W. R., & Barletta, R. G. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.1001 · Cited by 45
“The first propagation of foreign DNA into mycobacteria was achieved by means of a shuttle phasmid (phagemid) system [47], a chimera between a mycobacteriophage and an E.”
BackgroundSelf-citationDevelopment of BCG As a Recombinant Vaccine Vehicle
Jacobs, W. R., Snapper, S. B., Lugosi, L., & Bloom, B. R. (1990) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-74983-4_11 · Cited by 44
Self-citationOral Immunogenicity of Plant-MadeMycobacterium tuberculosisESAT6 and CFP10
Uvarova, E. A., Belavin, P. A., Permyakova, N. V., Zagorskaya, A. A., Носарева, О. В., Kakimzhanova, A., & Дейнеко, Е. В. (2013) · BioMed Research International · doi:10.1155/2013/316304 · Cited by 50
“…and Elena V. Deineko1 1 Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences, pr. Lavrentieva 10, Novosibirsk 630090, Russia 2 State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Oblast 630559, Russia 3 National Center of Biotechnology, ul.”
BackgroundHermans, J., Martı́n, C., Huijberts, G. N. M., Goosen, T., & de Bont, J. A. M. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb00803.x · Cited by 43
Flexner, C. W., Murphy, B. R., Rooney, J. F., Wohlenberg, C. R., Yuferov, V. P., Notkins, A. L., & Moss, B. (1988) · Nature · doi:10.1038/335259a0 · Cited by 43
Recombinant BCG as a candidate oral vaccine vector
Barletta, R. G., Snapper, B., Cirillo, J. D., Connell, N. D., Kim, D. D., Jacobs, W. R., & Bloom, B. R. (1990) · Research in Microbiology · doi:10.1016/0923-2508(90)90132-a · Cited by 42
Self-citationGene Transfer in Mycobacterium tuberculosis : Shuttle Phasmids to Enlightenment
Jacobs, W. R. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0037-2013 · Cited by 42
“Using the protoplast methodologies developed by Mervyn Bibb and David Hopwood (100), I focused on optimizing DNA transfer into M. smegmatis by assaying infectious centers formed after transfecting naked D29 phage DNA (4).”
BackgroundMethodInfluentialSelf-citationMayer, O., Jain, P., Weisbrod, T. R., Bíro, D., Ho, L., Jacobs‐Sera, D., Hatfull, G. F., & Jacobs, W. R. (2016) · Journal of Bacteriology · doi:10.1128/jb.00592-16 · Cited by 46
“In mycobacteria, shuttle phasmids (8) have been critical to the development of genetic manipulation systems for mycobacteria, including the development of transformation systems, transposon mutagenesis, recombination substitution mutagenesis, and transfer of point mutations (9–13), as reviewed extensively by Hatfull a…”
BackgroundSelf-citationLi, S., Ji, X., Harrison, T., Deng, C., Wang, S., Wang, L., & Zhu, R. (2020) · Palaeogeography Palaeoclimatology Palaeoecology · doi:10.1016/j.palaeo.2020.109794 · Cited by 41
Modeling Tubercular ESX-1 Secretion Using Mycobacterium marinum
Chirakos, A. E., Balaram, A., Conrad, W. H., & Champion, P. A. D. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00082-19 · Cited by 47
Tateishi, Y., Minato, Y., Baughn, A. D., Ohnishi, H., Nishiyama, A., Ozeki, Y., & Matsumoto, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-62287-2 · Cited by 39
Potential applications of molecular biology to the study of fish mycobacteriosis
Belas, R., Faloon, P. W., & Hannaford, A. (1995) · Annual Review of Fish Diseases · doi:10.1016/0959-8030(95)00004-6 · Cited by 45
Edelman, R., & Tacket, C. O. (1990) · International Reviews of Immunology · doi:10.3109/08830189009061764 · Cited by 39
The case for hypervirulence through gene deletion in Mycobacterium tuberculosis
ten Bokum, A., Movahedzadeh, F., Frita, R., Bancroft, G. J., & Stoker, N. G. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.06.003 · Cited by 40
The biology of the genus Mycobacterium
Grange, J. M. (1996) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1996.tb04592.x · Cited by 38
Kanekiyo, M., Matsuo, K., Hamatake, M., Hamano, T., Ohsu, T., Matsumoto, S., Yamada, T., Yamazaki, S., Hasegawa, A., Yamamoto, N., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8716-8723.2005 · Cited by 42
“Its recombinant form, rBCG, which has been used successfully to express foreign antigens and to induce immune responses, has been proposed as a vaccine candidate against a number of diseases (26, 32, 33), especially human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) (11, 13 , 30).”
BackgroundMolecular Genetics of Mycobacteriophages
Hatfull, G. F. (2015) · ASM Press eBooks · doi:10.1128/9781555818845.ch5 · Cited by 41
Kana, B. D., & Mizrahi, V. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.08.006 · Cited by 36
Mycobacteriophages: Cornerstones of Mycobacterial Research
Hatfull, G. F., & Jacobs, W. R. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch12 · Cited by 39
Self-citationThe present and future role of BCG vaccine in tuberculosis control
Gheorghiu, M. (1990) · Biologicals · doi:10.1016/1045-1056(90)90025-u · Cited by 38
Conjugative transfer of a shuttle plasmid forEscherichia colitoMycobacterium smegmatis
Lazraq, R., Clavel-Sérès, S., David, H. L., & Roulland-Dussoix, D. (1990) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1990.tb04189.x · Cited by 38
Use of Recombinant BCG as a Vaccine Delivery Vehicle
Stover, C. K., de la Cruz, V. F., Bansal, G. P., Hanson, M. S., Fuerst, T. R., Jacobs, W. R., & Bloom, B. R. (1992) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-3410-5_19 · Cited by 38
Self-citationGenetic transformation of mycobacteria
Hatfull, G. F. (1993) · Trends in Microbiology · doi:10.1016/0966-842x(93)90008-f · Cited by 38
Jain, P., Thaler, D. S., Maïga, M., Timmins, G. S., Bishai, W. R., Hatfull, G. F., Larsen, M. H., & Jacobs, W. R. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir454 · Cited by 36
“Tools for genetic engineering had to be developed to set the stage for mycobacterial reporter phages [46]; the creation and refinement of genetic engineering tools and methods with mycobacteriophages is ongoing.”
BackgroundSelf-citationKumar, V., Loganathan, P., Sivaramakrishnan, G. N., Kriakov, J., Dusthackeer, A., Subramanyam, B., Chan, J., Jacobs, W. R., & Rama, N. P. (2008) · Tuberculosis · doi:10.1016/j.tube.2008.02.007 · Cited by 36
Self-citationApramycin resistance as a selective marker for gene transfer in mycobacteria
Paget, E., & DAVIES, J. E. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.21.6357-6360.1996 · Cited by 36
“Gene transfer systems using shuttle cosmids (10) or phasmids (12), vectors derived from indigenous mycobacterial plasmids (13, 18, 23) and even the broad-host-range plasmid RSF1010 (8), have been developed.”
BackgroundYersinia enterocolitica O:9 as a potential live oral carrier for protective antigens
Sory, M., & Cornelis, G. (1988) · Microbial Pathogenesis · doi:10.1016/0882-4010(88)90028-9 · Cited by 36
Duan, X., Li, Y., Du, Q., Huang, Q., Guo, S., Xu, M., Lin, Y., Liu, Z., & Xie, J. (2016) · Scientific Reports · doi:10.1038/srep19695 · Cited by 39
Lim, E. M., Lagranderie, M., Grand, R. L., Rauzier, J., Gheorghiu, M., Gicquel, B., & Winter, N. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.1573 · Cited by 35
Prospects for a Vaccine to Prevent Lyme Disease in Humans
Wormser, G. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1267 · Cited by 35
The Genus Mycobacterium--Nonmedical
Hartmans, S., de Bont, J. A. M., & Stackebrandt, E. S. (2006) · Springer eBooks · doi:10.1007/0-387-30743-5_33 · Cited by 37
Mycobacterium bovisBacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease Control
Matsuo, K., & Yasutomi, Y. (2011) · Tuberculosis Research and Treatment · doi:10.1155/2011/574591 · Cited by 42
“Since a host-vector system in mycobacteria was developed in 1987 [6], recombinant BCG (rBCG) technology has been extensively applied in the development of vaccines against a variety of infectious diseases, including bacterial, viral, and parasitic infections in addition to TB [7, 8].”
BackgroundLive Bacterial Vaccines and Their Application as Carriers for Foreign Antigens
Dougan, G., SMITH, L., & Heffron, F. (1989) · Advances in veterinary science and comparative medicine · doi:10.1016/b978-0-12-039233-9.50012-3 · Cited by 34
Haeseleer, F., Pollet, J.-F., Haumont, M., Bollen, A., & Jacobs, P. (1993) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(93)90249-w · Cited by 34
Hellyer, T. J., Brown, I. N., Dale, J. W., & EASMON, C. S. F. (1991) · Journal of Medical Microbiology · doi:10.1099/00222615-34-4-225 · Cited by 34
Prospects for Oral Vaccination Using Recombinant Bacteria Expressing Viral Epitopes
Schödel, F. P. (1992) · Advances in virus research · doi:10.1016/s0065-3527(08)60041-x · Cited by 34
Jackson, M., Berthet, F.-X., Otal, I., Rauzier, J., Martı́n, C., Gicquel, B., & Guilhot, C. (1996) · Microbiology · doi:10.1099/00221287-142-9-2439 · Cited by 33
The Mycobacterium tuberculosis genome at 25 years: lessons and lingering questions
Koleske, B. N., Jacobs, W. R., & Bishai, W. R. (2023) · Journal of Clinical Investigation · doi:10.1172/jci173156 · Cited by 39
Self-citationEnhanced Specialized Transduction Using Recombineering in Mycobacterium tuberculosis
Tufariello, J. M., Malek, A., Vilchèze, C., Cole, L. E., Ratner, H. K., González, P. A., Jain, P., Hatfull, G. F., Larsen, M. H., & Jacobs, W. R. (2014) · mBio · doi:10.1128/mbio.01179-14 · Cited by 32
“coli as a plasmid and in mycobacteria as a phage and permits transfer of genetic material between the organisms (7).”
BackgroundSelf-citationCloning and characterization of the aroA gene from Mycobacterium tuberculosis
Garbe, T. R., Jones, C., Charles, I. G., Gordon Dougan, B., & Young, D. B. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.6774-6782.1990 · Cited by 32
“The recent development of techniques for the genetic manipulation of mycobacteria (15, 18, 31), on the other hand, permits an alternative approach to the design of potential antimycobacterial vaccines by construction of mutant strains of M.”
MethodLussow, A. R., Giudice, G. D., Rénia, L., Mazier, D., Verhave, J. P., Verdini, A. S., Pessi, A., Louis, J. A., & Lambert, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.2960 · Cited by 32
Petrova, Z. O., Broussard, G. W., & Hatfull, G. F. (2015) · Microbiology · doi:10.1099/mic.0.000120 · Cited by 33
“They were instrumental in mycobacterial transfection and transformation (Jacobs et al., 1987) and use of antibiotic-resistant selectable markers (Snapper et al.”
BackgroundCheadle, E. J., O’Donnell, D., Selby, P. J., & Jackson, A. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.784-794.2005 · Cited by 31
“shuttle plasmids (23), there has been much interest in the”
BackgroundO’Donnell, M. R., Pym, A. S., Jain, P., Munsamy, V., Wolf, A., Karim, F., Jacobs, W. R., & Larsen, M. H. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03530-14 · Cited by 31
Self-citationCao, B., Chen, X., Yamaryo‐Botté, Y., Richardson, M. B., Martin, K. L., Khairallah, G. N., Rupasinghe, T., O’Flaherty, R., O’Hair, R. A. J., Ralton, J. E., et al. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo302508e · Cited by 30
The biology of the genus Mycobacterium
Grange, J. M. (1996) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.1996.tb04827.x · Cited by 29
Loci of Mycobacterium avium ser2 gene cluster and their functions
Mills, J. A., McNeil, M., Belisle, J. T., Jacobs, W. R., & Brennan, P. J. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.16.4803-4808.1994 · Cited by 29
“unlike M avium, is amenable to available mycobacterial genetic systems (21, 22, 29).”
BackgroundSelf-citationGene expression and the development of live enteric vaccines
Charles, I. G., & Gordon Dougan, B. (1990) · Trends in biotechnology · doi:10.1016/0167-7799(90)90151-m · Cited by 29
Transfection ofActinomycesspp. by Genomic DNA of Bacteriophages from Human Dental Plaque
Yeung, M. K., & Kozelsky, C. S. (1997) · Plasmid · doi:10.1006/plas.1997.1285 · Cited by 28
Advances in Mycobacterial Genetics: New Promises for Old Diseases
Jacobs, W. R. (1992) · Immunobiology · doi:10.1016/s0171-2985(11)80472-9 · Cited by 28
Self-citationMycobacterium Phage Butters-Encoded Proteins Contribute to Host Defense against Viral Attack
Mageeney, C. M., Mohammed, H. T., Dies, M., Anbari, S., Cudkevich, N., Chen, Y., Buceta, J., & Ware, V. C. (2020) · mSystems · doi:10.1128/msystems.00534-20 · Cited by 27
“(2) When gp30 is released from interacting with gp31 at the membrane, it is liberated into the cytosol.”
BackgroundA Review on Mycobacteriophages: From Classification to Applications
Hosseiniporgham, S., & Sechi, L. A. (2022) · Pathogens · doi:10.3390/pathogens11070777 · Cited by 29
“This shuttle vector was a plasmid DNA of Escherichia coli that was fitted into the non-essential zone of TM4 mycobacteriophage [72].”
BackgroundResultInfluentialDevelopment of a new host vector system in mycobacteria
Goto, Y., Taniguchi, H., Udou, T., Mizuguchi, Y., & Tokunaga, T. (1991) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1991.tb04477.x · Cited by 27
Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer
Begnini, K. R., Buss, J. H., Collares, T. V., & Seixas, F. K. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6495-3 · Cited by 29
BCG: A modifier of immune responses to parasites
Frommel, D., & Lagrange, P. H. (1989) · Parasitology Today · doi:10.1016/0169-4758(89)90143-9 · Cited by 26
Building a genome engineering toolbox in nonmodel prokaryotic microbes
Freed, E. F., Fenster, J. A., Smolinski, S. L., Walker, J. E., Henard, C. A., Gill, R. T., & Eckert, C. A. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26727 · Cited by 26
Jain, P., Garing, S. H., Verma, D., Saranathan, R., Clute-Reinig, N., Gadwa, J., Peterson, C. M., Hermansky, G., Fernandez, A. A., Asare, E., et al. (2020) · Journal of Bacteriology · doi:10.1128/jb.00411-20 · Cited by 26
“and cloned into pMV261 derived plasmid (50, 51) using EcoRV/PsiI restriction sites.”
MethodSelf-citationNitric Oxide in Mycobacterium tuberculosis Infection
Chan, J., & Jl, F. (2002) · Springer eBooks · doi:10.1007/0-306-46816-6_14 · Cited by 27
Joseph, J., Saubi, N., Pezzat, E. B., & Gatell, J. M. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.6.827 · Cited by 24
The immune response to mycobacterial infection: Development of new vaccines
Collins, F. M. (1994) · Veterinary Microbiology · doi:10.1016/0378-1135(94)90049-3 · Cited by 32
Whiteford, D. C., Klingelhoets, J. J., Bambenek, M. H., & Dahl, J. L. (2010) · Microbiology · doi:10.1099/mic.0.045518-0 · Cited by 30
Genetic engineering of Mycobacterium tuberculosis: A review
Lamrabet, O., & Drancourt, M. (2012) · Tuberculosis · doi:10.1016/j.tube.2012.06.002 · Cited by 35
Genetic vaccination against tuberculosis
Lowrie, D. B., Silvan, C. L., & Tascon, R. E. (1997) · Springer Seminars in Immunopathology · doi:10.1007/bf00870266 · Cited by 22
“tuberculosis such as crippled virulence determinants [52].”
Zainuddin, Z., Kunze, Z. M., & Dale, J. W. (1989) · Molecular Microbiology · doi:10.1111/j.1365-2958.1989.tb00100.x · Cited by 22
A guide to Mycobacterium mutagenesis
Borgers, K., Vandewalle, K., Festjens, N., & Callewaert, N. (2019) · FEBS Journal · doi:10.1111/febs.15041 · Cited by 25
Srinivasan, J., Singh, O., Chakrabarti, S., & Talwar, G. P. (1995) · Infection and Immunity · doi:10.1128/iai.63.12.4907-4911.1995 · Cited by 21
“Various live vaccine vectors have been proposed as vehicles for delivery of antigens to the host (1, 8, 17, 23).”
BackgroundAfolabi, M. O., Ndure, J., Drammeh, A., Darboe, F., Mehedi, S.-R., Rowland‐Jones, S., Borthwick, N., Black, A. P., Ambler, G., John-Stewart, G. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078289 · Cited by 20
Expression of Foreign Genes in Mycobacteria
Burlein, J. E., Stover, C. K., Offutt, S., & Hanson, M. S. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch17 · Cited by 21
Development of New Vector Systems as Genetic Tools Applicable to Mycobacteria
Jeong, J.-A., Lee, H., Ko, I.-J., & Oh, J. (2013) · Journal of Life Science · doi:10.5352/jls.2013.23.2.290 · Cited by 19
“coli에서는 plasmid로서 복제되지만 mycobacteria 에서는 phage로서 기능을 하여 chromosomal DNA로 삽입된 다고 보고되어 있다[16, 35].”
Mycobacteriophages: An important tool for the diagnosis of Mycobacterium tuberculosis (Review)
FU, X., Ding, M., Zhang, N., & Li, J. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3440 · Cited by 23
“The first generation of luciferase reporter phages (LRPs) were developed successfully by Jacobs et al in 1993 (16).”
MethodApes and Tricksters: The Evolution and Diversification of Humans’ Closest Relatives
McNulty, K. P. (2010) · Evolution Education and Outreach · doi:10.1007/s12052-010-0251-z · Cited by 19
Advances in the development of molecular genetic tools for Mycobacterium tuberculosis
Chhotaray, C., Tan, Y., Mugweru, J., Islam, M. M., Hameed, H. M. A., Wang, S., Lu, Z., Wang, C., Li, X., Tan, S., et al. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2018.06.003 · Cited by 20
“coli as plasmids and in mycobacteria as phages, have been introduced (Jacobs et al., 1987; Bardarov et al., 1997; Cox et al., 1999).”
BackgroundRecombinant BCG as a vaccine vehicle to protect against tuberculosis
Triccas, J. A. (2010) · Bioengineered Bugs · doi:10.4161/bbug.1.2.10483 · Cited by 20
Progress on Development of the Live BCG Recombinant Vaccine Vehicle for Combined Vaccine Delivery
Hanson, M. S., LAPCEVICH, C. V., & HAUN, S. L. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44453.x · Cited by 19
Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections
Ouyang, X., Li, X., Song, J., Wang, H., Wang, S., Ren, F., Li, Z., & Song, N. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1277178 · Cited by 20
“…et al., 1989), as interest in their molecular biology arose, along with their exploitation as gene manipulation tools for mycobacteria arose (Jacobs et al., 1987; Lazraq et al., 1991; McNerney, 1999; Bardarov et al., 2002; Marinelli et al., 2008; Tufariello et al., 2014; Hatfull, 2018;…”
BackgroundYuan, S., Shi, C., Liu, L., & Han, W. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.485185 · Cited by 22
“coli--Mycobacteria shuttle phasmids [98].”
BackgroundMartín, C., & Gicquel, B. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(11)70019-2 · Cited by 20
Generation of Affinity-Tagged Fluoromycobacteriophages by Mixed Assembly of Phage Capsids
Piuri, M., Rondón, L., Urdániz, E., & Hatfull, G. F. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01016-13 · Cited by 18
“It was isolated in 1984 (20) and 75 used to construct the first shuttle phasmids (21).”
BackgroundO’Donnell, M. R., Larsen, M. H., Brown, T. S., Jain, P., Munsamy, V., Wolf, A., Uccellini, L., Karim, F., de Oliveira, T., Mathema, B., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01834-18 · Cited by 18
Self-citationMolecular Genetic Strategies for Identifying Virulence Determinants of Mycobacterium tuberculosis
Jacobs, W. R., & Bloom, B. R. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch18 · Cited by 18
Self-citationDavid, M., Lubinsky-Mink, S., Ben‐Zvi, A., Ulitzur, S., Khun, J., & Suissa, M. (1992) · Plasmid · doi:10.1016/0147-619x(92)90059-j · Cited by 18
Zheng, C., Xie, P., & Chen, Y. (2002) · Parasitology International · doi:10.1016/s1383-5769(01)00094-0 · Cited by 17
4 Bacterial Transformation with Plasmid DNA
Saunders, J. R., & Saunders, V. A. (1988) · Methods in microbiology · doi:10.1016/s0580-9517(08)70071-0 · Cited by 17
From Jenner to genes—the new vaccines
Brown, F. (1990) · The Lancet · doi:10.1016/0140-6736(90)90360-h · Cited by 17
The way ahead for vaccines and vaccination: symposium summary
Mitchell, G. F. (1988) · Vaccine · doi:10.1016/s0264-410x(88)80029-x · Cited by 17
Current status of tuberculosis and recombinant bacillus Calmette-Guérin vaccines
Ohara, N. (2012) · Journal of Oral Biosciences · doi:10.1016/j.job.2012.04.002 · Cited by 16
The Molecular Genetics of Mycobacterium tuberculosis
Hatfull, G. F. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80166-2_2 · Cited by 16
Metadata
- Authors
- Jacobs, W. R., Tuckman, M., & Bloom, B. R.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- Nature
- Published
- 1987-06-11
- Volume
- 327
- Issue
- 6122
- Pages
- 532-535
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2045944193
- Cited by
- 314
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 2 · 2021: 8 · 2020: 12 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 17 · 2013: 7 · 2012: 10
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- mycobacteria, shuttle vector, gene transfer, Mycobacterium smegmatis, BCG, recombinant phage, protective antigen, tuberculosis, leprosy, Mycobacterium avium subsp. paratuberculosis
- MeSH terms
- Bacteriophages, Cloning, Molecular, DNA Replication, DNA, Bacterial, DNA, Recombinant, Genetic Engineering, Genetic Vectors, Mycobacterium, Plasmids, Transfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.